tolevamer medication developed combat clostridium difficile associated potassium sodium polystyrene sulfonate never marketed tolevamer designed bind enterotoxins clostridium difficile since antibiotic properties harm gut flora early studies used sodium salt soon replaced potassium sodium salt prevent hypokalaemia often associated early noninferiority study versus vancomycin metronidazole clostridium difficile associated diarrhea cdad found half patients tolevamer group complete treatment versus vancomycin metronidazole groups cdad recurrence patients reaching clinical success reduced significantly tolevamer recurrence rate vancomycin metronidazole however good result tolevamer partly due high dropout rate group since tolevamer reach primary endpoint study development antiinfective drug article stub help wikipedia expanding httpsenwikipediaorgwikitolevamer